Xylocain (Lidocaine) Toxicity
What is Xylocain toxicity?
Xylocain is the brand name for lidocaine, a local anesthetic that blocks sodium channels to temporarily stop nerve signals. Xylocain toxicity (also called lidocaine toxicity) occurs when an excess amount of the drug enters the bloodstream, overwhelming the body’s ability to metabolize and eliminate it. The result is a spectrum of neurologic, cardiovascular, and systemic effects that can range from mild tingling to life‑threatening seizures or cardiac arrest.
Because lidocaine is widely used in dental work, minor surgery, dermatologic procedures, and even in some topical preparations, toxicity is uncommon but important to recognize quickly. The toxicity may be acute (after a single large dose or rapid intravascular injection) or chronic (after repeated applications or prolonged infusion).
Common Causes
The following situations are the most frequent contributors to lidocaine toxicity:
- Excessive dose – exceeding the recommended maximum (generally 4.5 mg/kg for infiltration, 7 mg/kg for epidural, 3 mg/kg for topical) or administering a cumulative dose too quickly.
- Intravascular injection – accidental entry of lidocaine into a blood vessel during a nerve block, dental injection, or epidural placement.
- Rapid intravenous infusion – high‑flow infusions used for anti‑arrhythmic therapy or procedural sedation without proper monitoring.
- Use of topical lidocaine patches or creams over large surface areas, especially on damaged skin, which increases systemic absorption.
- Impaired hepatic function – liver disease reduces the primary metabolic pathway (CYP3A4), causing drug accumulation.
- Drug interactions – concomitant use of other sodium‑channel blockers, CYP3A4 inhibitors (e.g., erythromycin, ketoconazole), or medications that lower the seizure threshold (e.g., tramadol).
- Renal failure – reduces clearance of lidocaine metabolites, raising serum concentrations.
- Extreme age – infants, newborns, and the elderly have reduced protein binding and metabolic capacity.
- Hypoxia or acidosis – conditions that enhance lidocaine’s ability to penetrate neuronal membranes, worsening neurotoxicity.
- Procedural errors – failure to aspirate before injecting, use of inappropriate needle length, or lack of real‑time ECG monitoring during high‑dose infusions.
Associated Symptoms
Lidocaine toxicity classically follows a biphasic pattern: early neurologic signs, followed by cardiovascular manifestations if the level keeps rising.
Early (Neurologic) Signs
- Tingling or “pins‑and‑needles” (paresthesia) around the mouth, lips, or extremities
- Mild dizziness or light‑headedness
- Metallic taste or a feeling of “numbness” in the tongue
- Visual disturbances (blurred vision, phosphene flashes)
- Auditory changes (ringing in the ears)
- Confusion, agitation, or anxiety
- Speech slurring (dysarthria)
Progressive (Severe) Neurologic Signs
- Muscle twitching or tremors
- Seizures (often generalized tonic‑clonic)
- Loss of consciousness
Cardiovascular Signs
- Bradycardia or tachycardia
- Hypotension
- Arrhythmias (especially ventricular ectopy, bundle‑branch block, or asystole)
- Cardiac conduction delay (prolonged PR or QRS intervals on ECG)
- Cardiac arrest in severe cases
Other Systemic Effects
- Respiratory depression (decreased rate or apnea)
- Metabolic acidosis
- Skin flushing or erythema
When to See a Doctor
Because lidocaine toxicity can evolve rapidly, seek professional care immediately if you experience any of the following after a procedure or after using a lidocaine product:
- Sudden numbness or tingling that spreads beyond the injection site
- Unexplained dizziness, light‑headedness, or feeling “fuzzy”
- Metallic or bitter taste in the mouth
- Blurred vision, ringing in the ears, or hearing changes
- Severe headache, confusion, or difficulty speaking
- Any seizure activity, even if brief
- Chest pain, palpitations, rapid or irregular heartbeat
- Low blood pressure, fainting, or feeling “about to pass out”
If you have a known liver or kidney disease, are pregnant, or are taking other medications that affect lidocaine metabolism, be extra vigilant and inform the health‑care provider promptly.
Diagnosis
Diagnosis combines a focused clinical assessment with laboratory and monitoring tools.
Clinical Evaluation
- Detailed history of lidocaine dose, route, timing, and any concomitant drugs.
- Physical exam targeting neurologic status (mental state, cranial nerves, motor tone)
- Cardiovascular assessment – pulse, blood pressure, and continuous ECG.
Laboratory Tests
- Serum lidocaine level – therapeutic range: 1.5–5 µg/mL; toxicity usually >5 µg/mL. Levels are most useful if drawn within 30 minutes of symptom onset.
- Arterial blood gas (ABG) – to detect respiratory depression or metabolic acidosis.
- Liver function tests (AST, ALT, bilirubin) and renal panel – to assess clearance capacity.
- Electrolytes – especially potassium, as hyper‑ or hypokalemia can aggravate arrhythmias.
Monitoring
- Continuous 5‑lead ECG with attention to QRS width and PR interval.
- Pulse oximetry and capnography (if airway compromise is suspected).
- In high‑risk settings, invasive arterial blood pressure monitoring.
Treatment Options
Management is directed at stabilizing the patient, limiting further lidocaine absorption, and enhancing elimination. Treatment should be performed in an emergency or intensive‑care setting.
Immediate First‑Aid Measures
- Call emergency services (911 or local equivalent) if severe symptoms occur.
- Position the patient on their side (recovery position) to protect the airway in case of seizures.
- Administer supplemental oxygen (≥ 10 L/min via non‑rebreather mask).
Pharmacologic & Supportive Care
- Airway and Breathing: Intubate if the patient cannot maintain airway patency or has prolonged seizures.
- Seizure control: Benzodiazepines are first‑line (e.g., diazepam 0.1 mg/kg IV, or lorazepam 0.1 mg/kg IV). If seizures persist, consider a short‑acting barbiturate (e.g., thiopental).
- Cardiovascular support:
- Infuse 100 % oxygen and treat hypotension with isotonic fluids.
- For bradycardia, give atropine 0.5 mg IV push; repeat every 3–5 min up to 3 mg.
- Vasopressors (e.g., ephedrine, norepinephrine) for refractory hypotension.
- Treat life‑threatening arrhythmias according to ACLS guidelines; lidocaine is generally avoided as it may worsen the toxicity.
- Enhance elimination:
- Intravenous lipid emulsion (ILE) therapy – 20 % Intralipid® 1.5 mL/kg bolus over 1 min, followed by 0.25 mL/kg/min infusion. This “lipid sink” sequesters lipophilic lidocaine and is now the recommended first‑line antidote for severe systemic toxicity (American Society of Regional Anesthesia, 2022).
- Consider activated charcoal if the toxin was ingested orally and the patient presents within 1 hour, provided the airway is protected.
- Monitoring duration: Continue ECG and neurologic checks for at least 6 hours after symptoms resolve, as delayed cardiotoxicity can occur.
Post‑Acute Care
- Observe in a step‑down unit or ICU until lidocaine levels fall below toxic range and the patient is neurologically intact.
- Address underlying contributors (e.g., adjust medication list, treat liver disease).
- Provide patient education on signs of recurrence and safe use of future local anesthetics.
Prevention Tips
Most cases of lidocaine toxicity are preventable with careful technique and awareness of risk factors.
- Know the maximum recommended dose for the specific route and patient weight.
- Always aspirate before injecting to confirm you are not inside a blood vessel.
- Use a slow, incremental injection (e.g., ≤ 1 mL per 10 seconds) for nerve blocks.
- For topical preparations, limit surface area and avoid application on broken skin.
- Check liver and kidney function before high‑dose or continuous infusions, especially in the elderly.
- Review the patient’s medication list for potential CYP3A4 inhibitors or other sodium‑channel blockers.
- Employ continuous ECG monitoring during procedures that require large doses or infusion.
- Educate patients to report early neurologic sensations (tingling, metallic taste) immediately.
- Maintain a readily available lipid emulsion kit in any setting where lidocaine is used for rapid treatment of unexpected toxicity.
Emergency Warning Signs
If any of the following appear, consider this a medical emergency requiring immediate intervention (call 911 or go to the nearest emergency department):
- Sudden seizure activity or uncontrolled convulsions
- Severe hypotension (systolic < 90 mm Hg) or shock
- Life‑threatening arrhythmias (ventricular tachycardia, ventricular fibrillation, asystole)
- Loss of consciousness or inability to arouse the patient
- Significant respiratory depression or apnea
- Rapid widening of the QRS complex on ECG (> 100 ms) indicating impending cardiac toxicity
**References**
- Mayo Clinic. Lidocaine (Topical) Side Effects. Retrieved 2024.
- American Society of Regional Anesthesia and Pain Medicine. Practice Advisory on Local Anesthetic Systemic Toxicity, 2022.
- National Institutes of Health. Lidocaine Toxicity. MedlinePlus, 2023.
- Cleveland Clinic. Local Anesthetic Systemic Toxicity (LAST). 2024.
- World Health Organization. Guidelines for Safe Use of Local Anesthetics, 2021.